Advanced Training in Urologic Oncology

泌尿肿瘤学高级培训

基本信息

  • 批准号:
    10646219
  • 负责人:
  • 金额:
    $ 31.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-22 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Urologic cancers impose a significant burden on the health of Americans with 63,000 individuals succumbing to the malignancies each year. These numbers are expected to rise over the next several decades as the population ages. At the same time, the pace of innovation and discovery in cancer-oriented translational science and health services research continues to accelerate. Thus, a well-prepared research-oriented work force capable of answering important scientific questions is needed. Unfortunately, traditional clinical training in urologic oncology falls short of this need. The goal of this T32 renewal application is to prepare urology trainees for academic careers in urologic oncology by providing a comprehensive research training program in translational laboratory science or health services research. This proposal is a renewal application to educate 2 research trainees per year for 2 years of training. The program is structured around a research project supervised by an individualized mentorship committee, including both research and methods mentors, an interactive and informative series of seminars and a required core curriculum that includes specific graduate level courses that may lead to a Master’s degree. Entrants to the program will choose between a translational laboratory science or health services research track depending on their interests. The program will ensure that each trainee: 1) design, implement, analyze and report a research project, 2) obtain formal instruction on fundamental research methods, 3) gain instruction on either fundamental principles of cancer biology (translational science track) or essential elements of conducting health services research (health services track) and 4) acquire requisite professional skills (e.g., grant writing) to support and sustain a research career.
泌尿科癌症对63,000个人的美国人的健康施加了重大的伯宁 每年发生恶性肿瘤。这些数字预计将在接下来的几十年中增加 人口年龄。同时,以癌症为导向的翻译中的创新和发现空间 科学与卫生服务研究继续加速。这是一项精心准备的面向研究的工作 需要能够回答重要科学问题的力量。不幸的是,传统的临床培训 泌尿科肿瘤学不足以满足这种需求。 T32更新应用的目的是准备泌尿外科 通过提供一项全面的研究培训计划 翻译实验室科学或卫生服务研究。该建议是对教育2的续签申请 研究学员每年进行2年的培训。该计划是围绕一个研究项目结构的 由个性化的辅导委员会监督,包括研究和方法指导者 互动和信息丰富的SEMIAR和必需的核心课程,包括特定的研究生 可能会导致硕士学位的水平课程。该程序的参赛者将在翻译之间进行选择 实验室科学或卫生服务研究的轨道取决于他们的兴趣。该计划将确保 每个学员:1)设计,实施,分析和报告研究项目,2) 基本研究方法,3)获得有关癌症生物学的任何基本原理的指导 (翻译科学轨道)或进行卫生服务研究的基本要素(卫生服务 轨道)和4)获得所需的专业技能(例如,授予写作)来支持和维持研究职业。

项目成果

期刊论文数量(63)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Medicare Accountable Care Organizations and Use of Potentially Low-Value Procedures.
医疗保险责任医疗组织和潜在低价值程序的使用。
  • DOI:
    10.1177/1553350618816594
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    1.5
  • 作者:
    Modi,ParthK;Kaufman,SamuelR;Borza,Tudor;Oliphant,BryantW;Ryan,AndrewM;Miller,DavidC;Shahinian,VahaknB;Ellimoottil,Chad;Hollenbeck,BrentK
  • 通讯作者:
    Hollenbeck,BrentK
Implications of the Merit-Based Incentive Payment System for Urology Practices.
  • DOI:
    10.1016/j.urology.2022.05.052
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Maganty, Avinash;Hollenbeck, Brent K.;Kaufman, Samuel R.;Oerline, Mary K.;Lai, Lillian Y.;Caram, Megan E., V;Shahinian, Vahakn B.
  • 通讯作者:
    Shahinian, Vahakn B.
Eradicating Racial Injustice in Medicine-If Not Now, When?
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer.
  • DOI:
    10.1002/cam4.6788
  • 发表时间:
    2023-12
  • 期刊:
  • 影响因子:
    4
  • 作者:
  • 通讯作者:
Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending.
  • DOI:
    10.1016/j.urology.2018.10.022
  • 发表时间:
    2019-03
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Modi PK;Hollenbeck BK;Oerline M;Weizer AZ;Montgomery JS;Kaffenberger SD;Ryan AM;Ellimoottil C
  • 通讯作者:
    Ellimoottil C
共 32 条
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
前往

Ganesh S Palapattu其他文献

MULTI-INSTITUTIONAL EVALUATION OF THE PREDICTIVE VALUE OF p53 IMMUNOHISTOCHEMICAL STAINING IN PATIENTS WITH pT1-2 N0 DISEASE AT RADICAL CYSTECTOMY
  • DOI:
    10.1016/s0022-5347(08)60206-2
    10.1016/s0022-5347(08)60206-2
  • 发表时间:
    2008-04-01
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Shahrokh F Shariat;Yair Lotan;Pierre I Karakiewicz;Yves Fradet;Raheela Ashfaq;John P Stein;Patrick J Bastian;Matthew E Nielsen;Nazareno Suardi;Francesco Montorsi;Susan Groshen;Stefan C Muller;Ganesh S Palapattu;Jerome Rigaud;Jose A Karam;Lukas C Heukamp;George J Netto;Seth P Lerner;Arthur I Sagalowsky;Richard J Cote
    Shahrokh F Shariat;Yair Lotan;Pierre I Karakiewicz;Yves Fradet;Raheela Ashfaq;John P Stein;Patrick J Bastian;Matthew E Nielsen;Nazareno Suardi;Francesco Montorsi;Susan Groshen;Stefan C Muller;Ganesh S Palapattu;Jerome Rigaud;Jose A Karam;Lukas C Heukamp;George J Netto;Seth P Lerner;Arthur I Sagalowsky;Richard J Cote
  • 通讯作者:
    Richard J Cote
    Richard J Cote
INFLUENCE OF SERUM TESTOSTERONE LEVEL AND BODY MASS INDEX ON SURVIVAL IN MEN TREATED WITH IMMEDIATE VERSUS DEFERRED ANDROGEN DEPRIVATION FOR NODE-POSITIVE PROSTATE CANCER AFTER PROSTATECTOMY AND PELVIC LYMPHADENECTOMY
  • DOI:
    10.1016/s0022-5347(09)60769-2
    10.1016/s0022-5347(09)60769-2
  • 发表时间:
    2009-04-01
    2009-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dragan J Golijanin;Eric A Singer;Yu-Hui Chen;Judith Manola;Ganesh S Palapattu;Edward M Messing
    Dragan J Golijanin;Eric A Singer;Yu-Hui Chen;Judith Manola;Ganesh S Palapattu;Edward M Messing
  • 通讯作者:
    Edward M Messing
    Edward M Messing
LYMPHOVASCULAR INVASION (LVI) IS INDEPENDENTLY ASSOCIATED WITH BLADDER CANCER RECURRENCE AND SURVIVAL IN PATIENTS WITH T1 AND NEGATIVE LYMPH NODES AT RADICAL CYSTECTOMY
  • DOI:
    10.1016/s0022-5347(08)61606-7
    10.1016/s0022-5347(08)61606-7
  • 发表时间:
    2008-04-01
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Amit Gupta;Shahrokh F Shariat;Pierre I Karakiewicz;Patrick J Bastian;Ganesh S Palapattu;Mark P Schoenberg;Seth P Lerner;Arthur I Sagalowsky;Yair Lotan
    Amit Gupta;Shahrokh F Shariat;Pierre I Karakiewicz;Patrick J Bastian;Ganesh S Palapattu;Mark P Schoenberg;Seth P Lerner;Arthur I Sagalowsky;Yair Lotan
  • 通讯作者:
    Yair Lotan
    Yair Lotan
EARLY CLINICAL APPLICATION OF DNA HAIRPIN TECHNOLOGY TO RAPIDLY INDENTIFY ESCHERICHIA COLI IN URINE
  • DOI:
    10.1016/s0022-5347(09)60398-0
    10.1016/s0022-5347(09)60398-0
  • 发表时间:
    2009-04-01
    2009-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Brock B. ONeil;Jennifer G. Rothschild;Christopher M. Strohsahl;Dwight Hardy;Ganesh S Palapattu;Benjamin L. Miller
    Brock B. ONeil;Jennifer G. Rothschild;Christopher M. Strohsahl;Dwight Hardy;Ganesh S Palapattu;Benjamin L. Miller
  • 通讯作者:
    Benjamin L. Miller
    Benjamin L. Miller
A CONDITIONAL NOMOGRAM FOR PREDICTION OF EARLY RECURRENCE OF BLADDER CANCER AFTER RADICAL CYSTECTOMY
  • DOI:
    10.1016/s0022-5347(08)61612-2
    10.1016/s0022-5347(08)61612-2
  • 发表时间:
    2008-04-01
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Claudio Jeldres;Shahrokh F Shariat;Nazareno Suardi;Yair Lotan;Amit Gupta;Arthur I Sagalowsky;Ganesh S Palapattu;Patrick J Bastian;Mark P Schoenberg;Amnon Vazina;Seth P Lerner;Pierre I Karakiewicz
    Claudio Jeldres;Shahrokh F Shariat;Nazareno Suardi;Yair Lotan;Amit Gupta;Arthur I Sagalowsky;Ganesh S Palapattu;Patrick J Bastian;Mark P Schoenberg;Amnon Vazina;Seth P Lerner;Pierre I Karakiewicz
  • 通讯作者:
    Pierre I Karakiewicz
    Pierre I Karakiewicz
共 8 条
  • 1
  • 2
前往

Ganesh S Palapattu的其他基金

Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction
代谢重新布线通过调节间质-上皮相互作用促进 AA PCa
  • 批准号:
    10652987
    10652987
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction
代谢重新布线通过调节间质-上皮相互作用促进 AA PCa
  • 批准号:
    10201526
    10201526
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction
代谢重新布线通过调节间质-上皮相互作用促进 AA PCa
  • 批准号:
    10434721
    10434721
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction
代谢重新布线通过调节间质-上皮相互作用促进 AA PCa
  • 批准号:
    10411396
    10411396
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction
代谢重新布线通过调节间质-上皮相互作用促进 AA PCa
  • 批准号:
    10081854
    10081854
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Project 2: Integrating a Novel MiPS-Based Next-Generation Sequencing Urine Assay for the Early Detection of Unfavorable Risk Prostate Cancer
项目 2:集成基于 MiPS 的新型下一代测序尿液检测,以早期检测不利的前列腺癌风险
  • 批准号:
    10705237
    10705237
  • 财政年份:
    2014
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Project 2: Integrating a Novel MiPS-Based Next-Generation Sequencing Urine Assay for the Early Detection of Unfavorable Risk Prostate Cancer
项目 2:集成基于 MiPS 的新型下一代测序尿液检测,以早期检测不利的前列腺癌风险
  • 批准号:
    10006871
    10006871
  • 财政年份:
    2014
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Project 2: Integrating a Novel MiPS-Based Next-Generation Sequencing Urine Assay for the Early Detection of Unfavorable Risk Prostate Cancer
项目 2:集成基于 MiPS 的新型下一代测序尿液检测,以早期检测不利的前列腺癌风险
  • 批准号:
    10251031
    10251031
  • 财政年份:
    2014
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
METABOLOMIC PROFILING AND BIOLOGIC BASIS OF RACIAL DISPARITY IN PROSTATE CANCER
前列腺癌种族差异的代谢组学分析和生物学基础
  • 批准号:
    8716699
    8716699
  • 财政年份:
    2012
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
METABOLOMIC PROFILING AND BIOLOGIC BASIS OF RACIAL DISPARITY IN PROSTATE CANCER
前列腺癌种族差异的代谢组学分析和生物学基础
  • 批准号:
    8857576
    8857576
  • 财政年份:
    2012
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:

相似海外基金

Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer
优化膀胱癌患者的戒烟治疗
  • 批准号:
    10371383
    10371383
  • 财政年份:
    2022
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Impact of Chemotherapy on Bladder Function in Children
化疗对儿童膀胱功能的影响
  • 批准号:
    10397688
    10397688
  • 财政年份:
    2020
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Impact of Chemotherapy on Bladder Function in Children
化疗对儿童膀胱功能的影响
  • 批准号:
    10038031
    10038031
  • 财政年份:
    2020
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Impact of Chemotherapy on Bladder Function in Children
化疗对儿童膀胱功能的影响
  • 批准号:
    10213024
    10213024
  • 财政年份:
    2020
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别:
Impact of Chemotherapy on Bladder Function in Children
化疗对儿童膀胱功能的影响
  • 批准号:
    10613910
    10613910
  • 财政年份:
    2020
  • 资助金额:
    $ 31.96万
    $ 31.96万
  • 项目类别: